News
Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...
Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...
Dow jumps 240 points after Trump-Japan deal; retail traders fuel meme stock gains while Tesla and Alphabet earnings loom on the trading radar.
Philip Morris International Inc. reported strong Q2 results, with smoke-free products driving growth. Click for why PM shares ...
Quest Diagnostics beat Q1 estimates with 15.2% revenue growth and lifted its 2025 guidance amid rising volumes and solid ...
16h
Zacks Investment Research on MSNPennyMac Financial (PFSI) Lags Q2 Earnings and Revenue EstimatesPennyMac Financial (PFSI) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $2.67 per share a year ago. These ...
Merck recently declared a Q4 dividend of $0.81 per share while also securing Health Canada's nod for KEYTRUDA® in cervical ...
Intuitive Surgical Inc. hit a trading volume crescendo on July 22, 2025, with a stunning $1.217 billion in shares swapped, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results